Scolaris Content Display Scolaris Content Display

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 1 No. Exposed to Allogeneic Blood (All Studies).
Figures and Tables -
Analysis 1.1

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 1 No. Exposed to Allogeneic Blood (All Studies).

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 2 No. Exposed to Allogeneic Blood (Transfusion Protocol).
Figures and Tables -
Analysis 1.2

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 2 No. Exposed to Allogeneic Blood (Transfusion Protocol).

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 3 No. Exposed to Allogeneic Blood (Type of Surgery).
Figures and Tables -
Analysis 1.3

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 3 No. Exposed to Allogeneic Blood (Type of Surgery).

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 4 No.Exposed to Allogeneic Blood ‐ (Washed vs Unwashed).
Figures and Tables -
Analysis 1.4

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 4 No.Exposed to Allogeneic Blood ‐ (Washed vs Unwashed).

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 5 No.Exposed to Allogeneic Blood (Timing).
Figures and Tables -
Analysis 1.5

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 5 No.Exposed to Allogeneic Blood (Timing).

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 6 Units of Allogeneic Blood Transfused (All Studies).
Figures and Tables -
Analysis 1.6

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 6 Units of Allogeneic Blood Transfused (All Studies).

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 7 Units of Allogeneic Blood Transfused (Transfusion Protocol).
Figures and Tables -
Analysis 1.7

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 7 Units of Allogeneic Blood Transfused (Transfusion Protocol).

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 8 Units of Allogeneic Blood Transfused (Type of Surgery).
Figures and Tables -
Analysis 1.8

Comparison 1 Cell Salvage ‐ Blood Transfused (All studies), Outcome 8 Units of Allogeneic Blood Transfused (Type of Surgery).

Comparison 2 Cell Salvage ‐ Blood Transfused (Washed vs Unwashed), Outcome 1 No. Exposed Allogeneic Blood (Cardiac).
Figures and Tables -
Analysis 2.1

Comparison 2 Cell Salvage ‐ Blood Transfused (Washed vs Unwashed), Outcome 1 No. Exposed Allogeneic Blood (Cardiac).

Comparison 2 Cell Salvage ‐ Blood Transfused (Washed vs Unwashed), Outcome 2 No. Exposed Allogeneic Blood (Orthopaedic).
Figures and Tables -
Analysis 2.2

Comparison 2 Cell Salvage ‐ Blood Transfused (Washed vs Unwashed), Outcome 2 No. Exposed Allogeneic Blood (Orthopaedic).

Comparison 2 Cell Salvage ‐ Blood Transfused (Washed vs Unwashed), Outcome 3 No. Exposed Allogeneic Blood (Vascular).
Figures and Tables -
Analysis 2.3

Comparison 2 Cell Salvage ‐ Blood Transfused (Washed vs Unwashed), Outcome 3 No. Exposed Allogeneic Blood (Vascular).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 1 No. Exposed to Allogeneic Blood (Active vs Control).
Figures and Tables -
Analysis 3.1

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 1 No. Exposed to Allogeneic Blood (Active vs Control).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 2 No. Exposed to Allogeneic Blood (Transfusion Protocol).
Figures and Tables -
Analysis 3.2

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 2 No. Exposed to Allogeneic Blood (Transfusion Protocol).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 3 No. Exposed to Allogeneic Blood (Type of Surgery).
Figures and Tables -
Analysis 3.3

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 3 No. Exposed to Allogeneic Blood (Type of Surgery).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 4 No. Exposed to Allogeneic Blood (Washed vs Unwashed).
Figures and Tables -
Analysis 3.4

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 4 No. Exposed to Allogeneic Blood (Washed vs Unwashed).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 5 No. Exposed to Allogeneic Blood (Timing).
Figures and Tables -
Analysis 3.5

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 5 No. Exposed to Allogeneic Blood (Timing).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 6 Units Allogeneic Blood Transfused (Active vs Control).
Figures and Tables -
Analysis 3.6

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 6 Units Allogeneic Blood Transfused (Active vs Control).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 7 Units of Allogeneic Blood Transfused (Transfusion Protocol).
Figures and Tables -
Analysis 3.7

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 7 Units of Allogeneic Blood Transfused (Transfusion Protocol).

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 8 Units Allogeneic Blood Transfused (Type of Surgery).
Figures and Tables -
Analysis 3.8

Comparison 3 Cell Salvage ‐ Blood Transfused (Active vs Control), Outcome 8 Units Allogeneic Blood Transfused (Type of Surgery).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 1 No. Exposed to Allogeneic Blood (Active vs Active).
Figures and Tables -
Analysis 4.1

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 1 No. Exposed to Allogeneic Blood (Active vs Active).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 2 No. Exposed to Allogeneic Blood (Transfusion Protocol).
Figures and Tables -
Analysis 4.2

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 2 No. Exposed to Allogeneic Blood (Transfusion Protocol).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 3 No. Exposed to Allogeneic Blood (Type of Surgery).
Figures and Tables -
Analysis 4.3

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 3 No. Exposed to Allogeneic Blood (Type of Surgery).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 4 No. Exposed to Allogeneic Blood (Washed vs Unwashed).
Figures and Tables -
Analysis 4.4

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 4 No. Exposed to Allogeneic Blood (Washed vs Unwashed).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 5 No. Exposed to Allogeneic Blood (Timing).
Figures and Tables -
Analysis 4.5

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 5 No. Exposed to Allogeneic Blood (Timing).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 6 Units Allogeneic Blood Transfused (Active vs Active).
Figures and Tables -
Analysis 4.6

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 6 Units Allogeneic Blood Transfused (Active vs Active).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 7 Units of Allogeneic Blood Transfused (Transfusion Protocol).
Figures and Tables -
Analysis 4.7

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 7 Units of Allogeneic Blood Transfused (Transfusion Protocol).

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 8 Units Allogeneic Blood Transfused (Type of Surgery).
Figures and Tables -
Analysis 4.8

Comparison 4 Cell Salvage ‐ Blood Transfused (Active vs Active), Outcome 8 Units Allogeneic Blood Transfused (Type of Surgery).

Comparison 5 Cell Salvage ‐ Blood Loss, Outcome 1 Total Blood Loss (All Studies).
Figures and Tables -
Analysis 5.1

Comparison 5 Cell Salvage ‐ Blood Loss, Outcome 1 Total Blood Loss (All Studies).

Comparison 5 Cell Salvage ‐ Blood Loss, Outcome 2 Total Blood Loss (Active vs Control).
Figures and Tables -
Analysis 5.2

Comparison 5 Cell Salvage ‐ Blood Loss, Outcome 2 Total Blood Loss (Active vs Control).

Comparison 5 Cell Salvage ‐ Blood Loss, Outcome 3 Total Blood Loss (Active vs Active).
Figures and Tables -
Analysis 5.3

Comparison 5 Cell Salvage ‐ Blood Loss, Outcome 3 Total Blood Loss (Active vs Active).

Comparison 6 Cell Salvage ‐ Blood Transfused (Language & Methodological Quality), Outcome 1 Language of Publication (All Studies).
Figures and Tables -
Analysis 6.1

Comparison 6 Cell Salvage ‐ Blood Transfused (Language & Methodological Quality), Outcome 1 Language of Publication (All Studies).

Comparison 6 Cell Salvage ‐ Blood Transfused (Language & Methodological Quality), Outcome 2 Methodological Quality (All Studies).
Figures and Tables -
Analysis 6.2

Comparison 6 Cell Salvage ‐ Blood Transfused (Language & Methodological Quality), Outcome 2 Methodological Quality (All Studies).

Comparison 7 Adverse Events & Other Outcomes, Outcome 1 Mortality ‐ All Studies.
Figures and Tables -
Analysis 7.1

Comparison 7 Adverse Events & Other Outcomes, Outcome 1 Mortality ‐ All Studies.

Comparison 7 Adverse Events & Other Outcomes, Outcome 2 Mortality ‐ CS vs Control.
Figures and Tables -
Analysis 7.2

Comparison 7 Adverse Events & Other Outcomes, Outcome 2 Mortality ‐ CS vs Control.

Comparison 7 Adverse Events & Other Outcomes, Outcome 3 Mortality ‐ Active vs Active.
Figures and Tables -
Analysis 7.3

Comparison 7 Adverse Events & Other Outcomes, Outcome 3 Mortality ‐ Active vs Active.

Comparison 7 Adverse Events & Other Outcomes, Outcome 4 Re‐operation for bleeding ‐ All Studies.
Figures and Tables -
Analysis 7.4

Comparison 7 Adverse Events & Other Outcomes, Outcome 4 Re‐operation for bleeding ‐ All Studies.

Comparison 7 Adverse Events & Other Outcomes, Outcome 5 Re‐operation for Bleeding ‐ CS vs Control.
Figures and Tables -
Analysis 7.5

Comparison 7 Adverse Events & Other Outcomes, Outcome 5 Re‐operation for Bleeding ‐ CS vs Control.

Comparison 7 Adverse Events & Other Outcomes, Outcome 6 Re‐operation for Bleeding ‐ Active vs Active.
Figures and Tables -
Analysis 7.6

Comparison 7 Adverse Events & Other Outcomes, Outcome 6 Re‐operation for Bleeding ‐ Active vs Active.

Comparison 7 Adverse Events & Other Outcomes, Outcome 7 Any Infection ‐ All Studies.
Figures and Tables -
Analysis 7.7

Comparison 7 Adverse Events & Other Outcomes, Outcome 7 Any Infection ‐ All Studies.

Comparison 7 Adverse Events & Other Outcomes, Outcome 8 Any Infection ‐ CS vs Control.
Figures and Tables -
Analysis 7.8

Comparison 7 Adverse Events & Other Outcomes, Outcome 8 Any Infection ‐ CS vs Control.

Comparison 7 Adverse Events & Other Outcomes, Outcome 9 Any Infection ‐ Active vs Active.
Figures and Tables -
Analysis 7.9

Comparison 7 Adverse Events & Other Outcomes, Outcome 9 Any Infection ‐ Active vs Active.

Comparison 7 Adverse Events & Other Outcomes, Outcome 10 Wound Complication ‐ All Studies.
Figures and Tables -
Analysis 7.10

Comparison 7 Adverse Events & Other Outcomes, Outcome 10 Wound Complication ‐ All Studies.

Comparison 7 Adverse Events & Other Outcomes, Outcome 11 Wound Complication ‐ CS vs Control.
Figures and Tables -
Analysis 7.11

Comparison 7 Adverse Events & Other Outcomes, Outcome 11 Wound Complication ‐ CS vs Control.

Comparison 7 Adverse Events & Other Outcomes, Outcome 12 Wound Complication ‐ Active vs Active.
Figures and Tables -
Analysis 7.12

Comparison 7 Adverse Events & Other Outcomes, Outcome 12 Wound Complication ‐ Active vs Active.

Comparison 7 Adverse Events & Other Outcomes, Outcome 13 Any Thrombosis ‐ All Studies.
Figures and Tables -
Analysis 7.13

Comparison 7 Adverse Events & Other Outcomes, Outcome 13 Any Thrombosis ‐ All Studies.

Comparison 7 Adverse Events & Other Outcomes, Outcome 14 Any Thrombosis ‐ CS vs Control.
Figures and Tables -
Analysis 7.14

Comparison 7 Adverse Events & Other Outcomes, Outcome 14 Any Thrombosis ‐ CS vs Control.

Comparison 7 Adverse Events & Other Outcomes, Outcome 15 Stroke ‐ All Studies.
Figures and Tables -
Analysis 7.15

Comparison 7 Adverse Events & Other Outcomes, Outcome 15 Stroke ‐ All Studies.

Comparison 7 Adverse Events & Other Outcomes, Outcome 16 Stroke ‐ CS vs Control.
Figures and Tables -
Analysis 7.16

Comparison 7 Adverse Events & Other Outcomes, Outcome 16 Stroke ‐ CS vs Control.

Comparison 7 Adverse Events & Other Outcomes, Outcome 17 Non‐Fatal Myocardial Infarction ‐ All Studies.
Figures and Tables -
Analysis 7.17

Comparison 7 Adverse Events & Other Outcomes, Outcome 17 Non‐Fatal Myocardial Infarction ‐ All Studies.

Comparison 7 Adverse Events & Other Outcomes, Outcome 18 Non‐Fatal Myocardial Infarction ‐ CS vs Control.
Figures and Tables -
Analysis 7.18

Comparison 7 Adverse Events & Other Outcomes, Outcome 18 Non‐Fatal Myocardial Infarction ‐ CS vs Control.

Comparison 7 Adverse Events & Other Outcomes, Outcome 19 Non‐Fatal Myocardial Infarction ‐ Active vs Active.
Figures and Tables -
Analysis 7.19

Comparison 7 Adverse Events & Other Outcomes, Outcome 19 Non‐Fatal Myocardial Infarction ‐ Active vs Active.

Comparison 7 Adverse Events & Other Outcomes, Outcome 20 Deep Vein Thrombosis (DVT).
Figures and Tables -
Analysis 7.20

Comparison 7 Adverse Events & Other Outcomes, Outcome 20 Deep Vein Thrombosis (DVT).

Comparison 7 Adverse Events & Other Outcomes, Outcome 21 Hospital Length of Stay (LOS).
Figures and Tables -
Analysis 7.21

Comparison 7 Adverse Events & Other Outcomes, Outcome 21 Hospital Length of Stay (LOS).

Table 1. MEDLINE strategy

1. cell$ sav$.mp.
2. cell$ salvage.mp.
3. blood transfusion, autologous/
4. autotransfusion$.mp.
5. auto‐transfusion$.mp.
6. blood salvage.mp.
7. autovac.mp.
8. solcotrans system.mp.
9. constavac.mp.
10. solcotrans.mp.
11. hemovac.mp.
12. BRAT.mp.
13. fresenius.mp.
14. consta vac.mp.
15. cell saver.mp.
16. dideco.mp.
17. electromedic.mp.
18. electromedics.mp.
19. gish biomedical.mp.
20. haemonetics.mp.
21. orth‐evac.mp.
22. pleur‐evac.mp.
23. sorenson.mp.
24. reinfusion system.mp.
25. sorin biomedical.mp.
26. or/1‐25
27. exp blood transfusion/
28. exp hemorrhage/
29. exp anesthesia/
30. transfusion$.mp.
31. bleed$.mp.
32. blood loss$.mp.
33. hemorrhag$.mp.
34. haemorrhag$.mp.
35. or/27‐34
36. 26 and 35
37. randomized controlled trial.pt.
38. controlled clinical trial.pt.
39. randomized controlled trials.sh.
40. random allocation.sh.
41. double blind method.sh.
42. single blind method.sh.
43. or/37‐42
44. clinical trial.pt.
45. exp Clinical trials/
46. (clin$ adj25 trial$).ti,ab.
47. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.
48. placebos.sh.
49. placebo$.ti,ab.
50. random$.ti,ab.
51. research design.sh.
52. or/44‐51
53. comparative study.sh.
54. exp Evaluation studies/
55. follow up studies.sh.
56. prospective studies.sh.
57. (control$ or prospectiv$ or volunteer$).ti,ab.
58. or/53‐57
59. 43 or 52 or 58
60. 36 and 59
61. animal/ not human/
62. 60 not 61

Figures and Tables -
Table 1. MEDLINE strategy
Comparison 1. Cell Salvage ‐ Blood Transfused (All studies)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 No. Exposed to Allogeneic Blood (All Studies) Show forest plot

47

3857

Risk Ratio (M‐H, Random, 95% CI)

0.61 [0.53, 0.71]

2 No. Exposed to Allogeneic Blood (Transfusion Protocol) Show forest plot

47

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Transfusion Protocol

38

2867

Risk Ratio (M‐H, Random, 95% CI)

0.63 [0.54, 0.73]

2.2 No Transfusion Protocol

9

990

Risk Ratio (M‐H, Random, 95% CI)

0.44 [0.22, 0.88]

3 No. Exposed to Allogeneic Blood (Type of Surgery) Show forest plot

47

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 Cardiac

23

1784

Risk Ratio (M‐H, Random, 95% CI)

0.77 [0.68, 0.87]

3.2 Orthopaedic

21

1887

Risk Ratio (M‐H, Random, 95% CI)

0.42 [0.32, 0.54]

3.3 Vascular

3

186

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.13, 2.36]

4 No.Exposed to Allogeneic Blood ‐ (Washed vs Unwashed) Show forest plot

47

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

4.1 Washed

21

1600

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.44, 0.68]

4.2 Unwashed

26

2174

Risk Ratio (M‐H, Random, 95% CI)

0.71 [0.60, 0.84]

5 No.Exposed to Allogeneic Blood (Timing) Show forest plot

46

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

5.1 Intra‐operative

7

564

Risk Ratio (M‐H, Random, 95% CI)

0.53 [0.35, 0.80]

5.2 Post‐operative

33

2877

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.57, 0.79]

5.3 Both Intra & Post‐operative

6

294

Risk Ratio (M‐H, Random, 95% CI)

0.57 [0.31, 1.04]

6 Units of Allogeneic Blood Transfused (All Studies) Show forest plot

27

1937

Mean Difference (IV, Random, 95% CI)

‐0.67 [‐0.89, ‐0.45]

7 Units of Allogeneic Blood Transfused (Transfusion Protocol) Show forest plot

27

Mean Difference (IV, Random, 95% CI)

Subtotals only

7.1 Transfusion Protocol

23

1544

Mean Difference (IV, Random, 95% CI)

‐0.61 [‐0.84, ‐0.37]

7.2 No Transfusion Protocol

4

393

Mean Difference (IV, Random, 95% CI)

‐1.26 [‐2.11, ‐0.40]

8 Units of Allogeneic Blood Transfused (Type of Surgery) Show forest plot

27

Mean Difference (IV, Random, 95% CI)

Subtotals only

8.1 Cardiac

17

1368

Mean Difference (IV, Random, 95% CI)

‐0.64 [‐0.90, ‐0.39]

8.2 Orthopaedic

7

383

Mean Difference (IV, Random, 95% CI)

‐0.89 [‐1.40, ‐0.39]

8.3 Vascular

3

186

Mean Difference (IV, Random, 95% CI)

0.02 [‐0.34, 0.38]

Figures and Tables -
Comparison 1. Cell Salvage ‐ Blood Transfused (All studies)
Comparison 2. Cell Salvage ‐ Blood Transfused (Washed vs Unwashed)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 No. Exposed Allogeneic Blood (Cardiac) Show forest plot

23

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

1.1 Washed

9

654

Risk Ratio (M‐H, Random, 95% CI)

0.61 [0.47, 0.80]

1.2 Unwashed

14

1130

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.78, 0.97]

2 No. Exposed Allogeneic Blood (Orthopaedic) Show forest plot

21

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Washed

9

760

Risk Ratio (M‐H, Random, 95% CI)

0.47 [0.34, 0.64]

2.2 Unwashed

12

1044

Risk Ratio (M‐H, Random, 95% CI)

0.42 [0.30, 0.60]

3 No. Exposed Allogeneic Blood (Vascular) Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 Washed

3

186

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.13, 2.36]

Figures and Tables -
Comparison 2. Cell Salvage ‐ Blood Transfused (Washed vs Unwashed)
Comparison 3. Cell Salvage ‐ Blood Transfused (Active vs Control)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 No. Exposed to Allogeneic Blood (Active vs Control) Show forest plot

28

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

1.1 Cell Salvage vs Control

28

2064

Risk Ratio (M‐H, Random, 95% CI)

0.60 [0.49, 0.73]

2 No. Exposed to Allogeneic Blood (Transfusion Protocol) Show forest plot

28

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Transfusion Protocol

24

1674

Risk Ratio (M‐H, Random, 95% CI)

0.63 [0.52, 0.77]

2.2 No Transfusion Protocol

4

390

Risk Ratio (M‐H, Random, 95% CI)

0.27 [0.02, 4.08]

3 No. Exposed to Allogeneic Blood (Type of Surgery) Show forest plot

28

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 Cardiac

14

1029

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.70, 0.93]

3.2 Orthopaedic

11

849

Risk Ratio (M‐H, Random, 95% CI)

0.35 [0.24, 0.52]

3.3 Vascular

3

186

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.13, 2.36]

4 No. Exposed to Allogeneic Blood (Washed vs Unwashed) Show forest plot

27

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

4.1 Washed

14

1110

Risk Ratio (M‐H, Random, 95% CI)

0.53 [0.39, 0.71]

4.2 Unwashed

13

834

Risk Ratio (M‐H, Random, 95% CI)

0.73 [0.59, 0.91]

5 No. Exposed to Allogeneic Blood (Timing) Show forest plot

28

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

5.1 Intra‐operative

5

382

Risk Ratio (M‐H, Random, 95% CI)

0.61 [0.39, 0.95]

5.2 Post‐operative

18

1462

Risk Ratio (M‐H, Random, 95% CI)

0.60 [0.46, 0.79]

5.3 Both

5

220

Risk Ratio (M‐H, Random, 95% CI)

0.52 [0.28, 0.98]

6 Units Allogeneic Blood Transfused (Active vs Control) Show forest plot

18

Mean Difference (IV, Random, 95% CI)

Subtotals only

6.1 Cell Salvage vs Control

18

1260

Mean Difference (IV, Random, 95% CI)

‐0.90 [‐1.23, ‐0.56]

7 Units of Allogeneic Blood Transfused (Transfusion Protocol) Show forest plot

18

Mean Difference (IV, Random, 95% CI)

Subtotals only

7.1 Transfusion Protocol

15

969

Mean Difference (IV, Random, 95% CI)

‐0.81 [‐1.16, ‐0.46]

7.2 No Transfusion Protocol

3

291

Mean Difference (IV, Random, 95% CI)

‐1.64 [‐2.96, ‐0.33]

8 Units Allogeneic Blood Transfused (Type of Surgery) Show forest plot

18

Mean Difference (IV, Random, 95% CI)

Subtotals only

8.1 Cardiac

11

866

Mean Difference (IV, Random, 95% CI)

‐0.97 [‐1.40, ‐0.55]

8.2 Orthopaedic

4

208

Mean Difference (IV, Random, 95% CI)

‐1.13 [‐1.78, ‐0.48]

8.3 Vascular

3

186

Mean Difference (IV, Random, 95% CI)

0.02 [‐0.34, 0.38]

Figures and Tables -
Comparison 3. Cell Salvage ‐ Blood Transfused (Active vs Control)
Comparison 4. Cell Salvage ‐ Blood Transfused (Active vs Active)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 No. Exposed to Allogeneic Blood (Active vs Active) Show forest plot

20

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

1.1 Cell Salvage (Active vs Active)

20

1836

Risk Ratio (M‐H, Random, 95% CI)

0.62 [0.50, 0.77]

2 No. Exposed to Allogeneic Blood (Transfusion Protocol) Show forest plot

20

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Transfusion Protocol

15

1236

Risk Ratio (M‐H, Random, 95% CI)

0.63 [0.50, 0.79]

2.2 No Transfusion Protocol

5

600

Risk Ratio (M‐H, Random, 95% CI)

0.59 [0.35, 1.00]

3 No. Exposed to Allogeneic Blood (Type of Surgery) Show forest plot

20

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

3.1 Cardiac

10

798

Risk Ratio (M‐H, Random, 95% CI)

0.70 [0.56, 0.87]

3.2 Orthopaedic

10

1038

Risk Ratio (M‐H, Random, 95% CI)

0.51 [0.38, 0.69]

4 No. Exposed to Allogeneic Blood (Washed vs Unwashed) Show forest plot

21

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

4.1 Washed

7

484

Risk Ratio (M‐H, Random, 95% CI)

0.54 [0.41, 0.73]

4.2 Unwashed

14

1390

Risk Ratio (M‐H, Random, 95% CI)

0.73 [0.56, 0.95]

5 No. Exposed to Allogeneic Blood (Timing) Show forest plot

21

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

5.1 Intra‐operative

3

222

Risk Ratio (M‐H, Random, 95% CI)

0.47 [0.27, 0.82]

5.2 Post‐operative

16

1535

Risk Ratio (M‐H, Random, 95% CI)

0.70 [0.55, 0.90]

5.3 Both

2

117

Risk Ratio (M‐H, Random, 95% CI)

0.71 [0.42, 1.22]

6 Units Allogeneic Blood Transfused (Active vs Active) Show forest plot

8

Mean Difference (IV, Random, 95% CI)

Subtotals only

6.1 Cell Salvage (Active vs Active)

8

627

Mean Difference (IV, Random, 95% CI)

‐0.44 [‐0.68, ‐0.19]

7 Units of Allogeneic Blood Transfused (Transfusion Protocol) Show forest plot

8

Mean Difference (IV, Random, 95% CI)

Subtotals only

7.1 Transfusion Protocol

7

525

Mean Difference (IV, Random, 95% CI)

‐0.39 [‐0.67, ‐0.12]

7.2 No Transfusion Protocol

1

102

Mean Difference (IV, Random, 95% CI)

‐0.69 [‐1.20, ‐0.18]

8 Units Allogeneic Blood Transfused (Type of Surgery) Show forest plot

8

Mean Difference (IV, Random, 95% CI)

Subtotals only

8.1 Cardiac

6

501

Mean Difference (IV, Random, 95% CI)

‐0.39 [‐0.67, ‐0.12]

8.2 Orthopaedic

2

126

Mean Difference (IV, Random, 95% CI)

‐0.69 [‐1.20, ‐0.18]

Figures and Tables -
Comparison 4. Cell Salvage ‐ Blood Transfused (Active vs Active)
Comparison 5. Cell Salvage ‐ Blood Loss

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Total Blood Loss (All Studies) Show forest plot

23

1624

Mean Difference (IV, Random, 95% CI)

‐41.44 [‐111.57, 28.69]

2 Total Blood Loss (Active vs Control) Show forest plot

18

1168

Mean Difference (IV, Random, 95% CI)

‐32.63 [‐122.30, 57.03]

3 Total Blood Loss (Active vs Active) Show forest plot

5

456

Mean Difference (IV, Random, 95% CI)

‐61.98 [‐179.47, 55.50]

Figures and Tables -
Comparison 5. Cell Salvage ‐ Blood Loss
Comparison 6. Cell Salvage ‐ Blood Transfused (Language & Methodological Quality)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Language of Publication (All Studies) Show forest plot

46

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

1.1 English

41

3583

Risk Ratio (M‐H, Random, 95% CI)

0.60 [0.51, 0.71]

1.2 Non‐English

5

234

Risk Ratio (M‐H, Random, 95% CI)

0.63 [0.49, 0.82]

2 Methodological Quality (All Studies) Show forest plot

46

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Grade B

35

2874

Risk Ratio (M‐H, Random, 95% CI)

0.64 [0.55, 0.75]

2.2 Grade C

11

918

Risk Ratio (M‐H, Random, 95% CI)

0.47 [0.28, 0.80]

Figures and Tables -
Comparison 6. Cell Salvage ‐ Blood Transfused (Language & Methodological Quality)
Comparison 7. Adverse Events & Other Outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mortality ‐ All Studies Show forest plot

15

1212

Risk Ratio (M‐H, Random, 95% CI)

1.22 [0.55, 2.70]

2 Mortality ‐ CS vs Control Show forest plot

11

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Cell Salvage vs Control

11

811

Risk Ratio (M‐H, Random, 95% CI)

1.53 [0.65, 3.61]

3 Mortality ‐ Active vs Active Show forest plot

4

401

Risk Ratio (M‐H, Random, 95% CI)

0.27 [0.03, 2.40]

4 Re‐operation for bleeding ‐ All Studies Show forest plot

14

1119

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.55, 1.81]

5 Re‐operation for Bleeding ‐ CS vs Control Show forest plot

8

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

5.1 Active vs Control

8

592

Risk Ratio (M‐H, Random, 95% CI)

1.08 [0.47, 2.48]

6 Re‐operation for Bleeding ‐ Active vs Active Show forest plot

6

527

Risk Ratio (M‐H, Random, 95% CI)

0.92 [0.39, 2.15]

7 Any Infection ‐ All Studies Show forest plot

13

1390

Risk Ratio (M‐H, Random, 95% CI)

0.74 [0.44, 1.25]

8 Any Infection ‐ CS vs Control Show forest plot

9

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

8.1 Cell Salvage vs Control

9

826

Risk Ratio (M‐H, Random, 95% CI)

0.75 [0.41, 1.37]

9 Any Infection ‐ Active vs Active Show forest plot

4

564

Risk Ratio (M‐H, Random, 95% CI)

0.35 [0.05, 2.63]

10 Wound Complication ‐ All Studies Show forest plot

9

730

Risk Ratio (M‐H, Random, 95% CI)

0.91 [0.46, 1.81]

11 Wound Complication ‐ CS vs Control Show forest plot

7

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

11.1 Active vs Control

7

504

Risk Ratio (M‐H, Random, 95% CI)

0.88 [0.42, 1.81]

12 Wound Complication ‐ Active vs Active Show forest plot

2

226

Risk Ratio (M‐H, Random, 95% CI)

1.24 [0.13, 11.75]

13 Any Thrombosis ‐ All Studies Show forest plot

7

497

Risk Ratio (M‐H, Random, 95% CI)

1.46 [0.56, 3.83]

14 Any Thrombosis ‐ CS vs Control Show forest plot

6

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

14.1 Active vs Control

6

379

Risk Ratio (M‐H, Random, 95% CI)

1.46 [0.56, 3.83]

15 Stroke ‐ All Studies Show forest plot

4

496

Risk Ratio (M‐H, Random, 95% CI)

0.65 [0.17, 2.50]

16 Stroke ‐ CS vs Control Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

16.1 Active vs Control

3

298

Risk Ratio (M‐H, Random, 95% CI)

0.73 [0.14, 3.72]

17 Non‐Fatal Myocardial Infarction ‐ All Studies Show forest plot

9

831

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.40, 1.43]

18 Non‐Fatal Myocardial Infarction ‐ CS vs Control Show forest plot

5

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

18.1 Active vs Control

5

448

Risk Ratio (M‐H, Random, 95% CI)

0.58 [0.28, 1.19]

19 Non‐Fatal Myocardial Infarction ‐ Active vs Active Show forest plot

4

383

Risk Ratio (M‐H, Random, 95% CI)

1.89 [0.51, 6.98]

20 Deep Vein Thrombosis (DVT) Show forest plot

4

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

20.1 Active vs Control

4

249

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.31, 2.77]

21 Hospital Length of Stay (LOS) Show forest plot

5

Mean Difference (IV, Random, 95% CI)

Subtotals only

21.1 Active vs Control

5

397

Mean Difference (IV, Random, 95% CI)

‐1.28 [‐2.65, 0.08]

Figures and Tables -
Comparison 7. Adverse Events & Other Outcomes